Cargando…

Dynamical Binding Modes Determine Agonistic and Antagonistic Ligand Effects in the Prostate-Specific G-Protein Coupled Receptor (PSGR)

We analysed the ligand-based activation mechanism of the prostate-specific G-protein coupled receptor (PSGR), which is an olfactory receptor that mediates cellular growth in prostate cancer cells. Furthermore, it is an olfactory receptor with a known chemically near identic antagonist/agonist pair,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolf, Steffen, Jovancevic, Nikolina, Gelis, Lian, Pietsch, Sebastian, Hatt, Hanns, Gerwert, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700038/ https://www.ncbi.nlm.nih.gov/pubmed/29167480 http://dx.doi.org/10.1038/s41598-017-16001-4

Ejemplares similares

Odorant Receptor 51E2 Agonist β-ionone Regulates RPE Cell Migration and Proliferation
por: Jovancevic, Nikolina, et al.
Publicado: (2017)

Evidence for a shape-based recognition of odorants in vivo in the human nose from an analysis of the molecular mechanism of lily-of-the-valley odorants detection in the Lilial and Bourgeonal family using the C/Si/Ge/Sn switch strategy
por: Wolf, Steffen, et al.
Publicado: (2017)

PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-κB
por: Rodriguez, M, et al.
Publicado: (2014)

The activation of OR51E1 causes growth suppression of human prostate cancer cells
por: Maßberg, Désirée, et al.
Publicado: (2016)

Deep Sequencing of the Human Retinae Reveals the Expression of Odorant Receptors
por: Jovancevic, Nikolina, et al.
Publicado: (2017)

Olfactory receptor Olfr78 (prostate-specific G protein-coupled receptor PSGR) expression in arterioles supplying skeletal and cardiac muscles and in arterioles feeding some murine organs
por: Mermer, Petra, et al.
Publicado: (2021)

Functional Characterization of Olfactory Receptors in the Thyroid Gland
por: Weidinger, Daniel, et al.
Publicado: (2021)

Agonist and antagonist TRUPATH assays for G protein-coupled receptors
por: DiBerto, Jeffrey F., et al.
Publicado: (2022)

Medium-chain fatty acids modulate myocardial function via a cardiac odorant receptor
por: Jovancevic, Nikolina, et al.
Publicado: (2017)

Investigation of olfactory function in a Panx1 knock out mouse model
por: Kurtenbach, Stefan, et al.
Publicado: (2014)

Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
por: Lagarde, Nathalie, et al.
Publicado: (2016)

Purinergic receptor antagonists inhibit odorant-mediated CREB phosphorylation in sustentacular cells of mouse olfactory epithelium
por: Dooley, Ruth, et al.
Publicado: (2011)

Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
por: Lee, Sehan, et al.
Publicado: (2017)

Identification of amino acids involved in histamine potentiation of GABA(A) receptors
por: Thiel, Ulrike, et al.
Publicado: (2015)

Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
por: Kokal, Miriam, et al.
Publicado: (2020)

Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
por: Patinote, Cindy, et al.
Publicado: (2020)

Restoration of bilateral motor coordination from preserved agonist-antagonist coupling in amputation musculature
por: Shu, Tony, et al.
Publicado: (2021)

A machine learning model for classifying G-protein-coupled receptors as agonists or antagonists
por: Oh, Jooseong, et al.
Publicado: (2022)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

The Agonist-antagonist Myoneural Interface
por: Herr, Hugh, et al.
Publicado: (2021)

Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain
por: Lagard, Camille, et al.
Publicado: (2016)

A simple open source bioinformatic methodology for initial exploration of GPCR ligands’ agonistic/antagonistic properties
por: Panagiotopoulos, Athanasios A., et al.
Publicado: (2020)

Efficiently Differentiating Agonists and Competitive Antagonists for Weak Allosteric Protein–Ligand Interactions with Linear Response Theory
por: Davolio, Anthony J., et al.
Publicado: (2023)

Identification of Glycyrrhiza as the rikkunshito constituent with the highest antagonistic potential on heterologously expressed 5-HT(3A) receptors due to the action of flavonoids
por: Herbrechter, Robin, et al.
Publicado: (2015)

Correction to: Restoration of bilateral motor coordination from preserved agonist-antagonist coupling in amputation musculature
por: Shu, Tony, et al.
Publicado: (2021)

Molecular evolution of a chordate specific family of G protein-coupled receptors
por: Kurtenbach, Stefan, et al.
Publicado: (2011)

Agonist-Antagonist Coactivation Enhances Corticomotor Excitability of Ankle Muscles
por: Kesar, Trisha M., et al.
Publicado: (2019)

Hedione Reduces Subjective Vicarious Stress
por: Pützer, Anika, et al.
Publicado: (2020)

(18)F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging
por: Yang, Min, et al.
Publicado: (2011)

Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer
por: Kawahara, Takashi
Publicado: (2020)

Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review
por: Nelson, Adam J., et al.
Publicado: (2023)

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
por: Liu, Zhi-Mei, et al.
Publicado: (2022)

Function-based high-throughput screening for antibody antagonists and agonists against G protein-coupled receptors
por: Ren, Huanhuan, et al.
Publicado: (2020)

A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain
por: Perkins, Arden, et al.
Publicado: (2014)

Relationship between the agonist activity of synthetic ligands of TRAIL-R2 and their cell surface binding modes
por: Chekkat, Neila, et al.
Publicado: (2018)

A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
por: Sugimura, Rumiko, et al.
Publicado: (2019)

Effectiveness of GnRH Antagonists and Agonists in Patients with Hormone-Sensitive Prostate Cancer: A Retrospective Study
por: Liu, Zhenghao, et al.
Publicado: (2022)

Androgen receptor agonist and antagonist reduce response of cytokine‐induced killer cells on prostate cancer cells
por: Pungsrinont, Thanakorn, et al.
Publicado: (2023)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Multitargeting nature of muscarinic orthosteric agonists and antagonists
por: Myslivecek, Jaromir
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4b0m6n05p2huupjdgoegr3c3ns